Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults.
Monika Sparber-SauerAndrea C FerrariDaniel KosztylaRuth LadensteinGiovanni CecchettoBernarda KazanowskaGiovanni ScarzelloGustaf LjungmanGiuseppe Maria MilanoFelix NiggliRita AlaggioChristian VokuhlMichela CasanovaThomas KlingebielAngelica ZinBernarda KazanowskaGianni BisognoPublished in: Pediatric blood & cancer (2022)
The use of an intensified regimen failed to show a significant improvement in tumor response and outcome of patients with localized HR-RMS, EES, and UDS.